It can be used in human trials for NKT cell activation.
Our α-GalCer (KRN7000, α-galactosylceramide) is a GMP-compliant product, ensuring high quality and safety. For more details, please refer to the catalog.
Inquire About This Product
basic information
High quality and safety assurance in compliance with GMP.
Price range
Delivery Time
※Delivery times may vary depending on capacity and quantity, so please feel free to contact us.
Applications/Examples of results
Please take a look at the catalog.
catalog（3）
Download All Catalogs![[Information] KRN7000 (GMP) Project](https://image.www.ipros.com/public/catalog/image/01/588/654847/IPROS49731326261566834006.jpeg?w=120&h=170)
Company information
At Accelvex, we provide advanced medical support such as therapeutic cell processing. In recent years, the progress in cancer immunotherapy has been remarkable, with an increasing number of new approaches to control the immune function in the body using molecular targeted therapies like antibody drugs and checkpoint inhibitors. The self-tumor cell vector "SynVC," developed with our technology, can present all the cancer antigens possessed by the patient's own cancer cells and tissues to the immune cells in the patient's body, allowing for the acquisition and memory of immunity specific to cancer antigens.